Immunization, Hib3 in Middle income

Middle income: Immunization, Hib3 was 77.1% in 2024. ◆ Volatile

Latest (2024)
77.1%
Change on year
up 1.3%
Rank
26th
of 43 groups
All-time high
77.1%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Immunization, Hib3 in Middle income, 1990–2024

0204060801990200720241990: 0 % of children ages 12-23 months1991: 0 % of children ages 12-23 months1992: 0 % of children ages 12-23 months1993: 0 % of children ages 12-23 months1994: 0 % of children ages 12-23 months1995: 0 % of children ages 12-23 months1996: 0 % of children ages 12-23 months1997: 0.021 % of children ages 12-23 months1998: 1 % of children ages 12-23 months1999: 1.7 % of children ages 12-23 months2000: 8.4 % of children ages 12-23 months2001: 8.6 % of children ages 12-23 months2002: 10.6 % of children ages 12-23 months2003: 11.3 % of children ages 12-23 months2004: 12.6 % of children ages 12-23 months2005: 13.5 % of children ages 12-23 months2006: 13.9 % of children ages 12-23 months2007: 16.2 % of children ages 12-23 months2008: 18.1 % of children ages 12-23 months2009: 28.5 % of children ages 12-23 months2010: 30.4 % of children ages 12-23 months2011: 32.1 % of children ages 12-23 months2012: 36 % of children ages 12-23 months2013: 42.2 % of children ages 12-23 months2014: 47.6 % of children ages 12-23 months2015: 57.8 % of children ages 12-23 months2016: 67.3 % of children ages 12-23 months2017: 69 % of children ages 12-23 months2018: 69.3 % of children ages 12-23 months2019: 71.3 % of children ages 12-23 months2020: 69 % of children ages 12-23 months2021: 69.6 % of children ages 12-23 months2022: 75.1 % of children ages 12-23 months2023: 76 % of children ages 12-23 months2024: 77.1 % of children ages 12-23 months

Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.

Analysis

The most recent figure for immunization, hib3 in Middle income is 77.1%, measured in 2024. That is the highest value across all 35 years on record.

That represents a change of up 1.3% on the previous year and up 62.0% over ten years.

Over the whole period, immunization, hib3 in Middle income peaked at 77.1% in 2024 and was at its lowest, 0.0%, in 1990.

That places Middle income 26th out of 43 groups with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Immunization, Hib3 in Middle income, year by year

Annual values for Immunization, Hib3 (% of children ages 12-23 months) in Middle income, 1990 to 2024.
Year % of children ages 12-23 months Change
1990 0.0%
1991 0.0%
1992 0.0%
1993 0.0%
1994 0.0%
1995 0.0%
1996 0.0%
1997 0.0%
1998 1.0% +4801.2%
1999 1.7% +65.0%
2000 8.4% +405.2%
2001 8.6% +2.1%
2002 10.6% +22.9%
2003 11.3% +6.7%
2004 12.6% +11.5%
2005 13.5% +7.5%
2006 13.9% +2.8%
2007 16.2% +16.9%
2008 18.1% +11.4%
2009 28.5% +57.5%
2010 30.4% +6.7%
2011 32.1% +5.7%
2012 36.0% +12.1%
2013 42.2% +17.3%
2014 47.6% +12.6%
2015 57.8% +21.4%
2016 67.3% +16.6%
2017 69.0% +2.5%
2018 69.3% +0.5%
2019 71.3% +2.8%
2020 69.0% -3.1%
2021 69.6% +0.8%
2022 75.1% +7.9%
2023 76.0% +1.3%
2024 77.1% +1.3%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.3% 0.0% 1.7% 10
2000s 14.2% 8.4% 28.5% 10
2010s 52.3% 30.4% 71.3% 10
2020s 73.4% 69.0% 77.1% 5

Countries ranked near Middle income

  1. 29 Albania 97.0% compare
  2. 29 Bangladesh 97.0% compare
  3. 29 Belgium 97.0% compare
  4. 29 Egypt 97.0% compare
  5. 29 Korea 97.0% compare
  6. 29 Latvia 97.0% compare
  7. 29 Malta 97.0% compare
  8. 29 Naoero 97.0% compare
  9. 29 Nepal 97.0% compare
  10. 29 Norway 97.0% compare
  11. 29 Saudi Arabia 97.0% compare
  12. 29 Singapore 97.0% compare
  13. 29 Sri Lanka 97.0% compare
  14. 29 Saint Kitts and Nevis 97.0% compare
  15. 29 Tajikistan 97.0% compare
  16. 29 Tunisia 97.0% compare
  17. 29 Viet Nam 97.0% compare

See the full ranking of 234 places →

More health data for Middle income

All data for Middle income →

Frequently asked questions

What is immunization, hib3 in Middle income?
Immunization, hib3 in Middle income was 77.1% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
What is the highest immunization, hib3 recorded in Middle income?
The highest recorded value was 77.1% in 2024.
What is the lowest immunization, hib3 recorded in Middle income?
The lowest recorded value was 0.0% in 1990.
How does Middle income rank for immunization, hib3?
Middle income ranks 26th out of 43 groups with data for 2024.
Is immunization, hib3 rising or falling in Middle income?
Over the last ten years it is up 62.0%. The long-run trend across the full record is volatile.
Where does this Middle income data come from?
The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Immunization, Hib3 in Middle income. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 11 September 2026, from https://health.statizoid.com/stat/immunization-hib3-percent-of-children-ages-12-23-months/middle-income/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/immunization-hib3-percent-of-children-ages-12-23-months/middle-income/">Immunization, Hib3 in Middle income</a> — Statizoid

About this data

Indicator
Immunization, Hib3 (% of children ages 12-23 months)
Unit
% of children ages 12-23 months
Source
WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
234 places, 5,441 data points, 1990–2024
Last refreshed

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.